MyMD Pharmaceuticals (MYMD) Short Interest Ratio & Short Volume $1.33 -0.09 (-6.34%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MyMD Pharmaceuticals Short Interest DataMyMD Pharmaceuticals (MYMD) has a short interest of 263,600 shares, representing 11.82% of the float (the number of shares available for trading by the public). This marks a -6.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 134,123 shares to cover all short positions.Current Short Interest263,600 sharesPrevious Short Interest283,200 sharesChange Vs. Previous Month-6.92%Dollar Volume Sold Short$485,024.00Short Interest Ratio1.1 Days to CoverLast Record DateJune 30, 2024Outstanding Shares2,370,000 sharesFloat Size2,230,000 sharesShort Percent of Float11.82%Today's Trading Volume31,860 sharesAverage Trading Volume134,123 sharesToday's Volume Vs. Average24% Short Selling MyMD Pharmaceuticals? Sign up to receive the latest short interest report for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMYMD Short Interest Over TimeMYMD Days to Cover Over TimeMYMD Percentage of Float Shorted Over Time Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. MyMD Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2024263,600 shares $485,024.00 -6.9%11.8%1.1 $1.84 6/15/2024283,200 shares $620,208.00 -12.0%12.9%1.2 $2.19 5/31/2024321,800 shares $598,548.00 +96.9%15.2%1.3 $1.86 5/15/2024163,400 shares $343,140.00 -23.8%7.7%0.8 $2.10 4/30/2024214,300 shares $660,044.00 -45.5%10.8%1 $3.08 4/15/2024393,000 shares $892,110.00 +260.2%20.6%1.8 $2.27 Get the Latest News and Ratings for MYMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/31/2024109,100 shares $260,749.00 +16.8%5.7%0.5 $2.39 3/15/202493,400 shares $268,992.00 +0.8%5.1%1.7 $2.88 2/29/202492,700 shares $317,961.00 -5.4%5.2%1.6 $3.43 2/15/202498,000 shares $320,460.00 -95.9%5.5%1.7 $3.27 1/31/20242,400,000 shares $360,000.00 -32.4%5.5%1.6 $0.15 1/15/20243,550,000 shares $699,350.00 +3.2%8.2%2.5 $0.20 12/31/20233,440,000 shares $889,928.00 +8.2%7.9%2.8 $0.26 12/15/20233,180,000 shares $731,400.00 -19.5%7.3%3.7 $0.23 11/30/20233,950,000 shares $1.11 million +17.9%9.3%5.4 $0.28 11/15/20233,350,000 shares $1.17 million +2.1%7.9%5.1 $0.35 10/31/20233,280,000 shares $1.39 million -9.6%8.7%5.4 $0.43 10/15/20233,630,000 shares $1.53 million +4.0%9.7%4.5 $0.42 9/30/20233,490,000 shares $2.07 million +19.1%9.3%4.1 $0.59 9/15/20232,930,000 shares $1.80 million -0.7%7.8%3.8 $0.61 8/31/20232,950,000 shares $2.81 million +7.7%8.0%4.1 $0.95 8/15/20232,740,000 shares $3.49 million -32.0%7.4%3.8 $1.28 7/31/20234,030,000 shares $5.84 million +13.8%12.0%5.6 $1.45 7/15/20233,540,000 shares $2.83 million -1.7%10.6%6.7 $0.80 6/30/20233,600,000 shares $5.40 million -2.7%10.7%7.4 $1.50 6/15/20233,700,000 shares $6.07 million +3.9%11.3%7.5 $1.64 5/31/20233,560,000 shares $6.19 million +11.3%10.9%6.5 $1.74 5/15/20233,200,000 shares $6.11 million -0.6%9.8%6.1 $1.91 4/30/20233,220,000 shares $5.83 million +6.3%9.9%6.4 $1.81 4/15/20233,030,000 shares $4.67 million +2.0%9.3%6 $1.54 3/31/20232,970,000 shares $5.11 million +44.2%9.1%6.4 $1.72 3/15/20232,060,000 shares $3.63 million +48.2%6.4%5.3 $1.76 2/28/20231,390,000 shares $2.65 million +47.8%4.3%4.6 $1.91 2/15/2023940,500 shares $2.17 million +18.7%2.9%3.7 $2.31 1/31/2023792,200 shares $2.14 million +9.8%2.4%3.4 $2.70 1/15/2023721,600 shares $1.10 million -1.1%2.2%4.4 $1.52 12/30/2022729,900 shares $839,385.00 -14.8%2.3%4.6 $1.15 12/15/2022856,600 shares $1.16 million -5.1%2.6%5.1 $1.35 11/30/2022902,400 shares $1.93 million +25.8%2.8%5.2 $2.14 11/15/2022717,200 shares $1.43 million +3.4%2.2%4.2 $1.99We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. 10/31/2022693,800 shares $1.92 million +1.5%2.1%3.2 $2.77 10/15/2022683,400 shares $1.58 million +1.6%2.1%2.8 $2.31 9/30/2022672,900 shares $1.76 million +5.4%2.1%2.4 $2.61 9/15/2022638,700 shares $2.22 million -6.4%2.0%2.1 $3.48 8/31/2022682,600 shares $2.55 million -2.4%2.0%2.5 $3.74 8/15/2022699,200 shares $3.02 million +24.8%2.0%2.7 $4.32 7/31/2022560,200 shares $2.25 million -25.5%1.7%2.7 $4.02 7/15/2022751,400 shares $3.08 million +102.2%2.3%4.7 $4.10 6/30/2022371,700 shares $806,589.00 -5.4%1.1%2.7 $2.17 6/15/2022392,700 shares $867,867.00 -0.7%1.2%5.7 $2.21 5/31/2022395,500 shares $1.19 million +2.5%1.2%5.7 $3.01 5/15/2022385,800 shares $887,340.00 -14.4%1.2%5.2 $2.30 4/30/2022450,900 shares $1.69 million +0.6%1.4%5.4 $3.74 4/15/2022448,200 shares $1.74 million +2.1%1.4%5 $3.89 3/31/2022439,000 shares $2.05 million -9.0%1.3%4.9 $4.66 3/15/2022482,500 shares $1.61 million -9.5%1.5%4.7 $3.34 2/28/2022533,000 shares $2.13 million +13.5%1.6%5.2 $3.99 2/15/2022469,700 shares $2.38 million -1.4%1.4%3.9 $5.06 1/31/2022476,400 shares $2.09 million -11.1%1.5%3.5 $4.38 1/15/2022536,000 shares $2.60 million -12.2%1.6%3.7 $4.86 12/31/2021610,600 shares $3.70 million -3.3%1.9%3.6 $6.06 12/15/2021631,600 shares $4.13 million -7.0%1.9%3.6 $6.54 11/30/2021678,900 shares $5.20 million -26.7%2.1%3.2 $7.66 11/15/2021925,700 shares $8.35 million +0.8%2.5%4.4 $9.02 10/29/2021918,500 shares $8.80 million +14.9%2.5%4.2 $9.58 10/15/2021799,500 shares $6.31 million -1.4%2.2%3 $7.89 9/30/2021810,600 shares $5.84 million +21.0%2.2%3.4 $7.20 9/15/2021669,700 shares $4.55 million +0.7%1.8%2.8 $6.79 8/31/2021665,300 shares $4.32 million -13.2%1.8%2.5 $6.50 8/13/2021766,400 shares $4.29 million No Change2.1%3.2 $5.60 MYMD Short Interest - Frequently Asked Questions What is MyMD Pharmaceuticals' current short interest? Short interest is the volume of MyMD Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 263,600 shares of MYMD short. 11.82% of MyMD Pharmaceuticals' shares are currently sold short. Learn More on MyMD Pharmaceuticals' current short interest. What is a good short interest ratio for MyMD Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYMD shares currently have a short interest ratio of 1.0. Learn More on MyMD Pharmaceuticals's short interest ratio. What is a good short interest percentage for MyMD Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.82% of MyMD Pharmaceuticals' floating shares are currently sold short. Is MyMD Pharmaceuticals' short interest increasing or decreasing? MyMD Pharmaceuticals saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 263,600 shares, a drop of 6.9% from the previous total of 283,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MyMD Pharmaceuticals' float size? MyMD Pharmaceuticals currently has issued a total of 2,370,000 shares. Some of MyMD Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MyMD Pharmaceuticals currently has a public float of 2,230,000 shares. How does MyMD Pharmaceuticals' short interest compare to its competitors? 11.82% of MyMD Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MyMD Pharmaceuticals: Aspira Women's Health Inc. (4.03%), IN8bio, Inc. (0.46%), PharmaCyte Biotech, Inc. (0.30%), Avalo Therapeutics, Inc. (0.52%), Trinity Biotech plc (1.12%), Cara Therapeutics, Inc. (1.33%), Biora Therapeutics, Inc. (4.13%), Mannatech, Incorporated (0.21%), Sensei Biotherapeutics, Inc. (1.35%), ImmunoPrecise Antibodies Ltd. (0.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks. What does it mean to sell short MyMD Pharmaceuticals stock? Short selling MYMD is an investing strategy that aims to generate trading profit from MyMD Pharmaceuticals as its price is falling. MYMD shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MyMD Pharmaceuticals? A short squeeze for MyMD Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYMD, which in turn drives the price of the stock up even further. How often is MyMD Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYMD, twice per month. The most recent reporting period available is June, 30 2024. More Short Interest Resources from MarketBeat Related Companies AWH Short Squeeze INAB Short Squeeze PMCB Short Squeeze AVTX Short Squeeze TRIB Short Squeeze CARA Short Squeeze BIOR Short Squeeze MTEX Short Squeeze SNSE Short Squeeze IPA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYMD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.